employer coverage glp-1 news october 2025 Shortage = Over Who Gets the Shot? GLP-1

Retatrutide is being developed for both obesity and type 2 diabetes but is not yet licensed for either indication in the UK

At Baton Rouge General, we offer a full range of weight management options, from bariatric surgery to non-surgical treatments with medications like GLP-1s

Jul 1 2024 Chaopreecha et al., Phytomedicine, doi:10.1016/j.phymed.2024.156279 (date from preprint) Andrographolide attenuates SARS-CoV-2 infection via an up-regulation of glutamate-cysteine ligase catalytic subunit (GCLC) In vitro study showing andrographolide attenuates infection of SARS-CoV-2 wildtype and omicron variants in human lung epithelial cells and monkey kidney cells

How do lipedema patients respond to GLP-1 RAs

Landmesser, U